HOME

Is It Lyme?

TICK-BORNE ILLNESSES

TESTING

Treatment

LATEST NEWS

Remove & AVOID

Favorite Links

LLMd Controversy

LLMD FUNDRAISERS

Neuropsychiatric

PREGNANCY

ART DOHERTY'S CHILDREN & LYME

Lyme Vaccine

Alternative

Meeting Info

Guest book

 

 

 

 

 

  

 Latest News

 

Please CLICK HERE for Urgent information about Our LLMDs!

 

Bills

Federal and State Bills on Lyme Disease
http://www.geocities.com/HotSprings/Oasis/6455/politics-links.html

 

Lyme Disease Initiative of 2001 (Introduced in the House) HR 1254 IH

To establish a program to provide for a reduction in the incidence and prevalence of Lyme disease.

http://www.lymediseaseassociation.org/hr1254.htm
Lyme Disease Initiative of 2001 (Introduced in the House) HR 1254 IH 
http://thomas.loc.gov/cgi-bin/query/z?c107:h.r.1254:%3A

 

Lyme and Infectious Disease Information and Fairness in Treatment (LIFT) Act (Introduced in the Senate)  

S 969 IS 
http://thomas.loc.gov/cgi-bin/query/z?c107:s.969:%3A

HR 2118 IH
http://thomas.loc.gov/cgi-bin/query/z?c107:h.r.2118:%3A

Lyme and Infectious Disease Information and Fairness in Treatment  (LIFT)  Act

Senate Bill - S.969                                                   House
Bill - HR.2118

Put the “Public” back in Public Health!  


ACTION NEEDED

The Lyme Disease Foundation, other Lyme groups, and public policy experts
worked very hard with Congressional members to craft LIFT.  LIFT provides a
needed public voice into Federal tick-borne disease programs.  

We need your support because the bills have an excellent chance of passage if
you act now! 

Have your Senators sign-on to S. 969 by having them contact Christie Onoda
(202-224-2823) in Senator Chris Dodd’s office or Sen. Rick Santorum.  Have
your Representative sign-on to HR. 2118 by having him/her contact Alan
Eisenberg (202-225-4276) in Rep. Greenwood's office or Chris Kukla
(202-225-6506) in Rep. Lowey's office.

Congress email addresses: www.Senate.gov, www.House.gov. Or call the Capital
Hill Operator 202-224-3121.

Encourage others to get their Congressional members to sign-on too!

ADVANTAGES OF THE BILL(s)

1. The new legislation was crafted, as agreed upon by members of Congress, to
respond to current needs and the General Accounting Office’s recent review of
Federal tick-borne activity.
2. It covers activity in all states and is not limited to just the top 10
states with LD cases.
3. The content is streamlined and passes through only 1 committee in the
Senate and 1 in the House before going to the floor for approval.  This
significantly increases the bills chance for passage.
4.  It establishes a Tick-Borne Advisory Committee in the Office of the
Director of the Department of Health and Human Services (DHHS) which:

• Provides Committee Reports on the governments actions balanced with public
need regarding: testing, misuse of the LD surveillance definition,
physician/public awareness, access to disability benefits, and problems
arising with insurer & medical licensing boards.
• Adheres to the Federal statutes required to establish such committees.
Other disease groups have found this type of committee a very effective
method for groups to work with government officials.
• Increases government responsiveness to public need and coordination of
activities.
• Has oversight and input into DHHS agency efforts. e.g. NIH, CDC, Social
Security Administration, FDA.
• Assures that a public voice and broad scientific opinion will be
represented in government actions.
• Includes uniform appointment method for committee members, with: 3
scientific community members with experience working with patient groups; 3
nonprofit advocate members; 3 clinicians with long-term experience working
with patients & groups; and 2 patient representatives.
• Includes diverse nonvoting government advisors from specific areas with
extensive experience.

5. Lists Findings that address: the severity of these diseases and costs to
society; patient problems with insurance and obtaining medical care;
physician retaliation for treating difficult cases; lack of a perfect test
hindering real solutions; and problems of adverse events for Lyme disease
vaccine volunteers.
6. Appropriates $7 million for the Department of Defense to establish a
research unit to protect our troops.
7. Appropriates $14 million for the Centers for Disease Control and
Prevention, doubling its tick disease budget to: develop improved tests,
include other tick-borne diseases, and reeducate others about the
inappropriate use of the LD case surveillance definition for diagnosis and
treatment decisions.  
8. Adheres to the wishes of Congress to not specify money for the National
Institutes of Health. This increases the bills chance of passing.

Thanks,
Karen V-Forschner

Karen Vanderhoof-Forschner, BS, MBA, CPCU, CLU
Lyme Disease Foundation, One Financial Plaza, Hartford, CT 06103    
860-525-2000   www.Lyme.org

..........................

Please write Letters

 

New York Times Magazine

In the New York Times Magazine June 18, 2001 edition, distributed Saturday17, there is an article entitled Stalking Dr. Steere by David Grann. (read it below) It is imperative that everyone nationwide immediately respond (no later than Monday 19) preferably by email or if not possible, by fax. ACTION Responses should include some of the following: · short and carefully worded so as not to be inflammatory which would validate the article's premise that the Lyme community is irrational and prone to violence. · Do not mention your doctors' names · Letters should not personally attack Steere or the author but should be factually based and directed at the issue. · Emphasize that it is improbable that many who get Lyme are treated and cured but continue with the same symptoms.

CC: Governor Pataki (gov.pataki@chamber.state.ny.us Gov. George Pataki State Capital Albany, NY 12224) Send to: NY Times Magazine E-mail magazine@NY Times.com FAX: 212 556-3830 NY Times Magazine 229 W. 43rd Street NY, NY 10036

http://www.nytimes.com/2001/06/17/magazine/17LYMEDISEASE.html

 

 

Investigation of Allen Steere, M.D.

Massachusetts Lyme Disease Coalition P.O. Box 1916 Mashpee, MA  02649 (508) 563-7033
Complaint Letters for Investigation of Allen C. Steere, Jr., MD
TO:  All Lyme Patients and Their Families Everywhere!!
The Massachusetts Board of Registration in Medicine is now considering an investigation of Dr. Allen C. Steere, Jr., for misdiagnosing and/or refusing to diagnose and adequately treat Lyme disease in patients with bonafide cases of Lyme.  It will take MANY active complaints to trigger a full investigation and force the Board of Registration to open up their archives.  (Massachusetts has, historically, had an abysmal record of NOT investigating medical complaints.  Usually 10 of 3,000 per year.)
We URGENTLY need the following Letters of Complaint NOW:
MISDIAGNOSIS OR REFUSED TREATMENT DUE TO:
1. direct contact with Dr. Allen Steere 2. direct contact with New England Medical Center (Tufts Univ.) in Boston 3. serological tests sent to Dr. Steere's Lab at New England Medical Center, or 4. the DOCUMENTED or EXPRESSED influence of Dr. Steere on other physicians or diagnostic centers.
ALL Letters of Complaint should be ADDRESSED and MAILED to: 
Massachusetts Board of Registration in Medicine     ATTN:  Consumer Protection Unit     10 West Street, 3rd Floor     Boston, MA  02111
COPIES of ALL Letters of Complaint should be FORWARDED to: 
Massachusetts Lyme Disease Coalition     P.O. Box 1916     Mashpee, MA  02649
Thanks everyone.  Please MOVE on this quickly!  We all know what is at stake in New York, Massachusetts and nationally regarding the future of effective Lyme diagnoses and treatments!! 

http://www.angelfire.com/or2/complaints/index.html

 

..........................

 

Conferences/ Events

 

The Lyme Disease Association's Third Annual National Lyme Disease Conference, Princeton, NJ,  Saturday, November 10, 2001 (CME'S pending) 

LDF 2002 Conference Dates - April 5th and 6th, Farmington, Connecticut, Marriott

 

..........................

In The Headlines

 

Fri Jul 13, 2001  9:55 pm
THE NEW YORK OBSERVER

Ticked at The Times: I Had Lyme!
by Bruce Feirstein


The worst thing I've ever been told came from the lips of a doctor at the State University of New York at Stony Brook Medical Center in June 1998. "You have neurological damage," said Patricia Coyle, a neurologist in her mid-40's who specializes in Lyme disease. She seemed tired and overworked as she read from my latest medical tests and 10-year history of misdiagnoses. "The Lyme spirochete has crossed into your central nervous system and affected the blood flow in your brain," she said. "It's affected your ability to think, speak, reason and remember."

http://www.observer.com/pages/story.asp?ID=4549

 

Fri Jul 13, 2001 
Different views of Lyme Disease

Different views of Lyme Disease from those afflicted by Laurie E. Leavy

The many facets to the story of Lyme Disease continue to evolve as new studies, new treatments and new controversies emerge. There are physicians, patients, HMO's, advocating agencies and legislators mixed in the fray.

http://www.northcountynews.com/sports2.htm

 

Boston Globe Online - Metro Region - Ticked off

Ticked off

Long-term sufferers of Lyme disease fight for help

By Anne Barnard, Globe Staff, 7/10/2001

The diagnosis - Lyme disease - was almost a relief. Finally, Linda Hilliard had an explanation for many, if not all, of the odd symptoms that had racked her body for seven years: fatigue, chills, headaches, arthritis, asthma, heart trouble.
''I had finally figured out what was the problem,'' recalled Hilliard, who quit her nursing job at a Boston teaching hospital because of her illness.
http://www.boston.com/dailyglobe2/191/metro/Ticked_off+.shtml

 

Doctors rethink Lyme disease 

By Marjory Sherman Eagle-Tribune Writer     July 8, 2001

The tiny deer tick, no bigger than a poppy seed, is causing a huge conflict in medicine. The controversy -- pitting doctors against patients, and dividing some doctors into opposing camps -- swirls over how to diagnose and treat Lyme disease, a serious illness spread by the tick.

http://www.eagletribune.com/framesets/searcharch.htm

 

In Lyme Disease Debate, Some Patients Feel Lost

By Jane Gross    July 7, 2001

HYDE PARK, N.Y. — Sandy Samelson could barely lift her head from her husband's shoulder when it was her turn to speak at a Lyme disease support group here in Dutchess County, where per capita incidence of the tick-borne infection is among the highest in the world.

 http://www.nytimes.com/2001/07/07/health/07LYME.html

 

Certainty and Uncertainty in Treatment of Lyme Disease

By PHILIP J. HILTS Keith Meyers/The New York Times

Deer and white-footed mice are carriers of the bacteria that cause Lyme disease. Deer ticks feed on the blood of those animals and can spread the disease to humans they bite.

http://www.nytimes.com/2001/07/10/health/10LYME.html?searchpv=nytToday

The Bitter Feud over LYMErix Big Pharma Takes on the Wrong Little Osp

by Pamela Weintraub Posted July 6, 2001 · Issue 106

Abstract: While Glaxo insists that LYMErix is safe and effective, the questions continue to mount. Is the vaccine provoking a raging, destructive immune response? Is it turning asymptomatic Lyme into symptomatic forms of infection? Is the disease definition itself arbitrary or wrong? And, finally, why are these questions being asked now, after LYMErix has already been released?

http://news.bmn.com/hmsbeagle/106/notes/feature3

 

Short dose of antibiotics helps against Lyme disease
Scott Gottlieb, New York
 
For the first time, doctors have shown that a quick dose of the antibiotic doxycycline can ward off Lyme disease after a tick bite.
 
Results of a second study published by the same journal suggest that long term antibiotic treatment may not help people who are seriously debilitated by symptoms of Lyme disease after initial treatment.
http://bmj.com/cgi/content/full/322/7301/1506/a

 

Stalking Dr. Steere Over Lyme Disease

By DAVID GRANN     June 17, 2001

Last year, Dr. Allen Steere, one of the world's most renowned medical researchers and rheumatologists, began to fear patients. It was not so much the ones he had treated, though he occasionally had to worry about them too, but the ones who had started to call his office, threatening him, claiming he was responsible for their suffering. They insisted that he was denying them treatment for an acute form of chronic Lyme disease, a strand of the ordinarily more modest infection that they believed slipped into the bloodstream undetected and remained there for years, causing joint pain, chronic fatigue, suicidal depression, paralysis and even death.

http://www.nytimes.com/2001/06/17/magazine/17LYMEDISEASE.html

 

Lyme Disease Is Hard to Catch and Easy to Halt, Study Finds

By GINA KOLATA    June 13, 2001

Lyme disease is very difficult to catch, even from a deer tick in a Lyme-infested area, and can easily be stopped in its tracks with a single dose of an antibiotic, a new study shows.

And two other studies conclude that prolonged and intensive treatment with antibiotics, a course of care advocated by a small group of doctors, does nothing for people with symptoms often attributed to chronic Lyme disease. These findings are in keeping with the assertions of researchers who say that in most cases, such symptoms have nothing at all to do with the disorder.

http://www.nytimes.com/2001/06/13/health/13LYME.html

 

..........................

Clinical Studies

 

Lyme disease patient studies and trials

http://www.geocities.com/HotSprings/Oasis/6455/studies-links.html#studies

 

A National Institute of Health-Funded Treatment Study of Chronic Lyme Disease

Principal Investigator :Brian A. Fallon, MD

http://www.columbia-lyme.org/dept/nyspi/flatp/NIHstud-n.html

 

..........................

Medical Headlines

 

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

Mark S. Klempner, M.D., Linden T. Hu, M.D., Janine Evans, M.D., Christopher H. Schmid, Ph.D., Gary M. Johnson, Richard P. Trevino, B.S., DeLona Norton, M.P.H., Lois Levy, M.S.W., Diane Wall, R.N., John McCall, Mark Kosinski, M.A., and Arthur Weinstein, M.D. PDF of this Article ABSTRACT Background It is controversial whether prolonged antibiotic treatment is effective for patients in whom symptoms persist after the recommended antibiotic treatment for acute Lyme disease. Methods We conducted two randomized trials: one in 78 patients who were seropositive for IgG antibodies to Borrelia burgdorferi at the time of enrollment and the other in 51 patients who were seronegative. The patients received either intravenous ceftriaxone, 2 g daily for 30 days, followed by oral doxycycline, 200 mg daily for 60 days, or matching intravenous and oral placebos. Each patient had well-documented, previously treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptoms, or dysesthesia, often associated with fatigue. The primary outcome measures were improvement on the physical- and mental-health-component summary scales of the Medical Outcomes Study 36-item Short-Form General Health Survey (SF-36) - a scale measuring the health-related quality of life - on day 180 of the study. http://www.nejm.org/earlyrelease/feature.asp?strXMLFilename=20010712/0107120 2&strDate=7%2F12%2F2001&strArt=02&strNumber=2&strInstance=1#Table2

 

Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after an Ixodes scapularis Tick Bite
http://content.nejm.org/cgi/content/abstract/345/2/79

 

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
http://content.nejm.org/cgi/content/abstract/345/2/85

Letter from NIH-newsgroup post

The following is from sci.med:

Subject: MY ANSWER FROM NIH,AND IM NOT HAPPY WITH IT
Newsgroups: sci.med.diseases.lyme
Date: 2001-07-13 18:44:24 PST

This is in response to your inquiry of June 20, 2001, to the National Institutes of Health (NIH) Information Office regarding Lyme disease research.  Your message was forwarded to the National Institute of Allergy and Infectious Diseases (NIAID) for response. The New England Medical Center study, funded by NIAID, is one of several ongoing studies attempting to characterize patients with persisting symptoms.  The patients in this study were a well-defined group who had a positive blood test for Lyme disease or a skin rash that is typical of early Lyme disease (erythema migrans) documented by a physician, had been previously treated with antibiotics, and still have continuing (chronic) symptoms. The lack of response to extended antibiotic treatment in this particular study population suggests that their symptoms are not caused by a persistent infection. The results suggest that we need to define the cause or causes of the debilitating, persisting symptoms experienced by some patients with Lyme disease. Understanding the origin of these symptoms should lead to more effective therapeutic approaches to ameliorate these symptoms. The participants in the NEMC study have agreed to continue to be further evaluated to find the cause of their ongoing symptoms which may include co-existing infection with other tick-borne diseases, a genetic susceptibility to develop an ongoing response to past infection, a particularly virulent strain of the Lyme agent (B. burgdorferi), or some other cause. Regarding your concern that the study did not report some patients whose symptoms improved, this study was carefully designed to ferret out any significant difference between those treated and those given a placebo or "dummy" pill.  You may be interested to know that, while 55 percent of patients treated with antibiotics improved, 42 percent of patients in the placebo groups also improved. Conversely, 14 percent of the patients in the antibiotic groups had worsened health status, as compared with 19 percent (10 of 53) in the placebo groups.  The data safety and monitoring board decided to halt the treatment because the statistical likelihood of seeing a significant benefit of treatment would be so very small (3.9%) if the study were fully enrolled and carried out to completion. Be assured that research on chronic symptoms of Lyme disease continues. You may wish to review a description of NIAID's ongoing chronic Lyme disease research, discussed at http://www.niaid.nih.gov/research/lyme.htm
and http://www.niaid.nih.gov/spotlight/bugborne01/lyme.htm

We hope that this information helps to clarify the goals of the
Institute's research direction and offers some assurance that NIH is committed to advancing understanding of this disease and determining the best treatment
for patients.
NIAID Correspondence Specialist
Office of Communications and Public Liaison

 

A Review of the Review Article by Allen C. Steere, M.D. Medical Progress Lyme Disease

http://www.geocities.com/HotSprings/Retreat/1593/comments-steere-12jun01.htm
l

 

CNN - Tick spit study may stop sickness - June 26, 1998

You've been bitten, but don't know it
From Correspondent Ann Kellan

http://www.cnn.com/TECH/science/9806/26/t_t/tick.spit/

 

CNN - Chemist plots ticks' fungal demise - March 25, 1998

Researchers hope to use fungi to combat deer tick populations

By Environmental News Network staff Watch out Lyme disease-carrying black-legged deer ticks -- chemist Patricia Allen wants to make you so sick you die.

http://www.cnn.com/EARTH/9803/25/tick.fungi/index.html

 

Borrelia burgdorferi - The Taxonomy and Genetics of the Lyme Disease Bacteria

Lyme disease is a serious bacterial infection caused by a tick bite and affects humans and animals. This page contains MEDLINE search links to citations and abstracts for medical and scientific articles at the National Institutes of Health (NIH), National Library of Medicine (NLM) MEDLINE database. http://www.geocities.com/HotSprings/Oasis/6455/burgdorferi-links.html

 

TOP of PAGE

3308
HOMEIs It Lyme?TICK-BORNE ILLNESSES TestingTreatmentLATEST NEWSRemove & AVOIDFavorite LinksLLMd ControversyLLMD FUNDRAISERSNeuropsychiatricPREGNANCYART DOHERTY'S CHILDREN & LYME Lyme VaccineAlternativeMeeting InfoGuest book